secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001140361-25-039793
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cartesian Therapeutics Chair Carrie Cox resigns; CEO Carsten Brunn named Chairman, bylaw amended
--------------------------------------------------------------------------------

- Carrie Cox resigned from the Board and as Chair on Oct. 29, 2025, to focus on other commitments; not related to any disagreement.
- Carsten Brunn, Ph.D., CEO and Board member, appointed Chairman of the Board effective immediately.
- Patrick Zenner named Lead Independent Director; Kemal Malik appointed Chairman of the Compensation Committee.
- Board approved amended and restated Bylaws to incorporate references to Lead Independent Director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000114036125039793/0001140361-25-039793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000114036125039793/ef20057980_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-039793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer